It is therefore unclear what changes in the ATM under IRE1α deletion are accountable for the protection against obesity and insulin resistance as observed in the myeloid-specific IRE1α knockout model (Shan, Wang et al. 2017). The gene discussed is ATM; the disease is Insulin resistance.